Document is current
Any future updates will be listed below
-
Authors
Winden, Kellen
Bebin, E. Martina
Jeste, Shafali
Krueger, Darcy A.
Paul, Elahna
Sahin, Mustafa https://orcid.org/0000-0001-7044-2953
- License Information
-
More Information
Article History
Accepted: 16 February 2026
First Online: 12 March 2026
Competing interests
: E.M.B. declares currently active membership of scientific advisory boards for Apertura Gene Therapy and Cassava Sciences Inc. S.J. declares membership of the safety monitoring committee for Ionis Pharmaceuticals (Angelman syndrome ASO phase II trial). D.A.K. declares membership of scientific advisory boards for Jazz Pharmaceuticals and Aeovian Pharmaceuticals, and grant support from Jazz Pharmaceuticals. M.S. declares membership of scientific advisory boards for Neurogene and Noema; chairmanship of the scientific advisory board for PTEN Research; and grant support from Biogen, Gondalobio and Neurvati. K.W. and E.P. declare no competing interests.
